While a number of asthma medications are available as generics, Aerobid is not. The patent for Aerobid has now expired; however, it is impossible to tell when there will be a generic Aerobid medicine. It is important to remember that flunisolide is the active ingredient in Aerobid, not a generic version of the medication.
An Overview of Generic Aerobid
Aerobid inhalers will not be made, dispensed, or sold in the United States after June 30, 2011. Aerobid contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. People taking Aerobid should ask their healthcare providers about alternatives to Aerobid, keeping in mind that it is possible that Aerobid may become unavailable in pharmacies earlier than the final date.
Aerobid® (flunisolide inhaler) is a prescription medication used to prevent asthma attacks. It is part of a class of asthma drugs known as inhaled corticosteroids.
Aerobid is manufactured by Forest Pharmaceuticals. The patent for Aerobid expired in June 2007. However, there are not any generic Aerobid versions available at this time.
The patent for Aerobid expired in June 2007. Currently, there are no approved generic versions of Aerobid. This may be because generic manufacturers have not yet chosen to make a generic version of Aerobid, or it could be because the United States Food and Drug Administration (FDA) has not approved any generic versions (or may in the process of reviewing such products). At this time, it is impossible to know when a generic Aerobid drug may become available.